Skip to main content
. 2019 Apr 2;39(4):BSR20182018. doi: 10.1042/BSR20182018

Figure 1. FBXL19-AS1 was up-regulated in BC.

Figure 1

(A) QRT-PCR was used to explore FBXL19-AS1 expression in BC tissues and ANT. (B) FBXL19-AS1 expression was increased in BC patients with LM compared with patients with NLM. (C) FBXL19-AS1 expression was up-regulated in BC patients with TNM stage II + III compared with TNM stage I. (D) FBXL19-AS1 expression in BC was analyzed by using GEPIA database. (E) FBXL19-AS1 was slightly up-regulated at stages I–IV and X using GEPIA database. (F) QRT-PCR was used to explore FBXL19-AS1 expression in BC cell lines and normal mammary fibroblast cells. *P<0.05.

Abbreviation: NLM, none lymphnode metastasis.